bordetella,
DESCRIPTION
powerpoint presentation on B.pertussisTRANSCRIPT
1
2
GENUS BORDETELLAGENUS BORDETELLA
3
Bordetella is a genus of small (0.2 - 0.7 µm), Gram-negative coccobacilli of the phylum proteobacteria. Obligate aerobes , non fermentative & highly fastidious. Three species are human pathogens B. pertussis, B. parapertussis, B. bronchiseptica); B. bronchiseptica is motile.
4
B. pertussis and occasionally B. parapertussis cause pertussis. Some B. parapertussis strains can colonise sheep. B. bronchiseptica rarely infects healthy humans. It causes several diseases like kennel cough and atrophic rhinitis in dogs and pigs, respectively.
Causes several diseases in human and animals
5
Obligate Obligate Aerobe.Aerobe.Fastidious.Fastidious.
Complex medium.Complex medium. ““Bordet – Gengou –Bordet – Gengou –
Glycerin – Potato Blood Glycerin – Potato Blood
Agar”.Agar”. Charcoal agar with Charcoal agar with
10% blood10% blood
Cultural charactersCultural characters
Can’t grow on Mac Can’t grow on Mac Conkey agar. Conkey agar.
Growth is slow (3 – 10 Growth is slow (3 – 10 days).Small, smooth, days).Small, smooth, dome shaped & opaque.dome shaped & opaque.
Viscid, grayish white and Viscid, grayish white and refractile.refractile.
Bisected pearls / Bisected pearls / Mercury drop.Mercury drop.
Confluent growth: Confluent growth:
“ “Aluminum paint” “Thumb print” appearance.
6
Heat 55Heat 5500 C /30 minutes. C /30 minutes. Drying , disinfectants.Drying , disinfectants. Storage: At 0 – 4Storage: At 0 – 400 C. C. On dried droplets survive On dried droplets survive
upto Hours to days.upto Hours to days.
Non fermentor.Non fermentor. Biochemically Biochemically
inertinert Oxidase positive.Oxidase positive. Catalase positive.Catalase positive.
Survival conditions and Biochemical tests for identification
7
1. Pertussis toxin:1. Pertussis toxin: Protein. M.W. 1,17,000 , A & B units.Protein. M.W. 1,17,000 , A & B units. Can be toxoided. Antibody is protective.Can be toxoided. Antibody is protective. Increased concentration of Increased concentration of cAMP cAMP in the in the
cell. cell. Lymphocytosis Lymphocytosis Increased sensitivity to histamine .Increased sensitivity to histamine . Islet cell activation Islet cell activation leads toleads to insulin secretion.insulin secretion. Hemaggulatinating property.Hemaggulatinating property.
Virulence factors contributing their Virulence factors contributing their pathogenesispathogenesis
Lipopolysacharide ,Activates the alternative pathway
of complement and release cytokines.
8
Present on bacillary
surface.
Facilitates adhesion of
bacilli to ciliated columnar
epithelium of respiratory
tract.
Promotes secondary
infection
“Piracy of adhesions”
phenomenon.
2.Filamentous haemaggutinin:
9
4. Invasive Adenylate cyclase:4. Invasive Adenylate cyclase: Responsible for hemolysis on blood agarResponsible for hemolysis on blood agar.. Activated by Activated by Calmodulin.Calmodulin. Release of cAMPRelease of cAMP..
5. Lethal toxin: 5. Lethal toxin: Inflammation & Necrosis.Inflammation & Necrosis.
6. Tracheal cytotoxin:6. Tracheal cytotoxin:
Normal product of breakdown of the Normal product of breakdown of the
cellwall.cellwall.
Induces production of IL-1 Induces production of IL-1 fever. fever.
Induces paralysis of ciliary escalator.Induces paralysis of ciliary escalator.
Inhibits DNA synthesis. Inhibits DNA synthesis.
10
Pertussis An acute, highly contagious
respiratory pediatric disease. Source is patient in early stage Droplets, contaminated fomites. Incubation period is1 – 2 weeks. Onset is insidious.
Pathogenesis: They share everything including Bordetella
11
1.Catarrhal stage:1.Catarrhal stage:
Stage of infectivity.Stage of infectivity.
Like common cold.Like common cold.
Low grade fever, running Low grade fever, running
nose, nasal congestion, nose, nasal congestion,
Sneezing.Sneezing.
Dry irritating cough.Dry irritating cough.
Clinical diagnosis difficult.Clinical diagnosis difficult.
Respond to antibioticsRespond to antibiotics. .
12
2. 2. Paroxysmal phaseParoxysmal phase
•Bouts (paroxysms) of Bouts (paroxysms) of
coughing:coughing:
At the end of each boutAt the end of each bout a a
long inspiratory effort is long inspiratory effort is
usually accompanied by a usually accompanied by a
characteristic high-pitched characteristic high-pitched
sound sound “whoop”.“whoop”. •Duration of this stage is 1 Duration of this stage is 1
– 6 weeks.– 6 weeks.((Due to difficulty in expelling thick mucus from the airways in the
lungs. More in first 1-2 wks. and constant for another 2 wks).
13
•During an attack,During an attack, the the
individual may become individual may become
cyanoticcyanotic due to lack due to lack
of of oxygenoxygen..
•Children and young Children and young
infantsinfants appear especially appear especially
ill and distressed.ill and distressed. Conjunctival hemorrhages &cyanotic patches on the face
14
Convalescent stage (Recovery Convalescent stage (Recovery stage)stage)
3 – 4 weeks after an acute illness paroxysms are 3 – 4 weeks after an acute illness paroxysms are decreased.decreased.
Complications:Complications: Subconjunctival & Subconjunctival & Cerebral hemorrhage.hemorrhage. Subcutaneous emphysema.Subcutaneous emphysema. Bronchopneumonia & Lung collapse. Convulsions due to permanent brain damage. Anoxic encephalopathy. Developmental retardation
15
Epidemiology:Epidemiology: Most infectious,air borne bacterial Most infectious,air borne bacterial
disease.disease. No reservoir. Chronic carrier state not No reservoir. Chronic carrier state not
seen.seen. World wide (600,000 million cases World wide (600,000 million cases
annually). annually).
6,00,000 deaths occurs in epidemics.6,00,000 deaths occurs in epidemics. Prominent in infants and children.Prominent in infants and children. In adolescents & adults presentIn adolescents & adults present
atypically as bronchitis.atypically as bronchitis.
16
Lab diagnosis :Lab diagnosis :
1. Demonstration of antigen:1. Demonstration of antigen:
Nasopharyngeal secretions.Nasopharyngeal secretions.
By using calcium alginate /Dacron swabBy using calcium alginate /Dacron swab
Urine and Serum.Urine and Serum.
Immunofluorecent method.Immunofluorecent method.
False positive :False positive :
Staphylococci, Yeasts,Staphylococci, Yeasts,
Hemophilus, Moraxella. Hemophilus, Moraxella.
17
3. Culture 3. Culture Best in early stages of disease.Best in early stages of disease.
No use with Transport medium.No use with Transport medium.
Requires 3 -10 days.Requires 3 -10 days.
Specimens:Specimens:
1. Cough plate method:1. Cough plate method:
2. Per oral swab:2. Per oral swab:
secretions from secretions from
posterior pharyngeal wall.posterior pharyngeal wall.
3. Per nasal swab: Better.3. Per nasal swab: Better.
With highest yieldsWith highest yields..
18
2. Demonstration of antibody (late).2. Demonstration of antibody (late).
Serum, Nasopharyngeal secretions ( Ig A).Serum, Nasopharyngeal secretions ( Ig A).
Useful for retrospective diagnosis.Useful for retrospective diagnosis.
Increased antibody titer.Increased antibody titer.
Method:Method: Agglutination, Agglutination, ELISA. ELISA.
19
IgM and IgAIgM and IgA antibodies antibodies are diagnostic. are diagnostic. Early/acute infection and Early/acute infection and followed by vaccination.followed by vaccination.
PCR testing:PCR testing: Quite Quite
sensitive. (Be aware of sensitive. (Be aware of cross reaction with cross reaction with Bordetella holmesii.)Bordetella holmesii.)
CBC :CBC : Elevated WBC Elevated WBC count with count with lymphocytosis.lymphocytosis.
20
Specific immunization:Specific immunization:
Killed vaccine ( smooth phase I strain)Killed vaccine ( smooth phase I strain)
(Detoxication with 0.2% (Detoxication with 0.2% merthiolate)merthiolate)..
Types:Types:
1. Whole cell vaccine.1. Whole cell vaccine.
2. Acellular vaccine for below 7 yrs age2. Acellular vaccine for below 7 yrs age
protective components.protective components.
(PT + FHA + Factors 1,2,3)(PT + FHA + Factors 1,2,3)
Prevention of spreading and Prevention of spreading and Vaccine availabilityVaccine availability
21
Available as:Available as:
1. Plain vaccine1. Plain vaccine
2. Alum absorbed vaccine PT2. Alum absorbed vaccine PT
3. Triple vaccine DPT or DTaP3. Triple vaccine DPT or DTaP
Dosage:Dosage:
‘‘3’ injections IM at 4 – 6 weeks.3’ injections IM at 4 – 6 weeks.
11stst dose at the age of 2 months. dose at the age of 2 months.
Vaccination is safe with protection rate Vaccination is safe with protection rate
of 90%.of 90%.
22
Local soreness , fever , Local soreness , fever ,
shock, Convulsions, shock, Convulsions,
encephalopathyencephalopathy Provocate the Provocate the
poliomyelitis.poliomyelitis.
Contra indicated Contra indicated
incase of severe side incase of severe side
effects with previous effects with previous
dose.dose.
Side effects followed by vaccination
23
•Erythromycin for 14
days.
•Cough suppressants.
•Corticosteroids.
•Pertussis immunoglobulins
:Limited success
Treatment for acute case
24
During epidemics:During epidemics: Immunization is not 100% Immunization is not 100%
effective and slowly becomes effective and slowly becomes less effective.less effective.
Health care providers, Health care providers, adolescents & others at risk are adolescents & others at risk are advised to receive a booster advised to receive a booster dose.dose.
Un immunized children < 7 yrs Un immunized children < 7 yrs should be excused from school should be excused from school and public gatherings for 14 and public gatherings for 14 days.days.
Health warning Health warning announcements.announcements.
25
PREVENTIVE MEASURES
26
Created by
Dr P.S.Reddy MDProfessor, Dept. of Microbiology
Narayana Medical College,
Nellore AP, INDIA
For e-learning